These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 28782576)
21. Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting. Heiss JA; Brenner H Clin Epigenetics; 2017; 9():24. PubMed ID: 28270869 [TBL] [Abstract][Full Text] [Related]
22. Identification of DNA methylation biomarkers for risk of liver metastasis in early-stage colorectal cancer. Li W; Guo L; Tang W; Ma Y; Wang X; Shao Y; Zhao H; Ying J Clin Epigenetics; 2021 Jun; 13(1):126. PubMed ID: 34108011 [TBL] [Abstract][Full Text] [Related]
23. Roles of Methylated DNA Biomarkers in Patients with Colorectal Cancer. Ma Z; Williams M; Cheng YY; Leung WK Dis Markers; 2019; 2019():2673543. PubMed ID: 30944663 [TBL] [Abstract][Full Text] [Related]
24. Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue. Levin TR; Corley DA; Jensen CD; Marks AR; Zhao WK; Zebrowski AM; Quinn VP; Browne LW; Taylor WR; Ahlquist DA; Lidgard GP; Berger BM Dig Dis Sci; 2017 Mar; 62(3):678-688. PubMed ID: 28044229 [TBL] [Abstract][Full Text] [Related]
25. Uncovering potential genes in colorectal cancer based on integrated and DNA methylation analysis in the gene expression omnibus database. Wang G; Wang F; Meng Z; Wang N; Zhou C; Zhang J; Zhao L; Wang G; Shan B BMC Cancer; 2022 Feb; 22(1):138. PubMed ID: 35114976 [TBL] [Abstract][Full Text] [Related]
26. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas. Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530 [TBL] [Abstract][Full Text] [Related]
27. Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC. Rademakers G; Massen M; Koch A; Draht MX; Buekers N; Wouters KAD; Vaes N; De Meyer T; Carvalho B; Meijer GA; Herman JG; Smits KM; van Engeland M; Melotte V Clin Epigenetics; 2021 Apr; 13(1):80. PubMed ID: 33858496 [TBL] [Abstract][Full Text] [Related]
28. Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer. Patnaik S; Anupriya Front Pharmacol; 2019; 10():588. PubMed ID: 31244652 [TBL] [Abstract][Full Text] [Related]
29. Identification of novel DNA methylation markers in colorectal cancer using MIRA-based microarrays. Li H; Du Y; Zhang D; Wang LN; Yang C; Liu B; Wang WJ; Shi L; Hong WG; Zhang L; Yang YX Oncol Rep; 2012 Jul; 28(1):99-104. PubMed ID: 22552777 [TBL] [Abstract][Full Text] [Related]
30. Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer. Oh T; Kim N; Moon Y; Kim MS; Hoehn BD; Park CH; Kim TS; Kim NK; Chung HC; An S J Mol Diagn; 2013 Jul; 15(4):498-507. PubMed ID: 23747112 [TBL] [Abstract][Full Text] [Related]
31. Genes CEP55, FOXD3, FOXF2, GNAO1, GRIA4, and KCNA5 as potential diagnostic biomarkers in colorectal cancer. Hauptman N; Jevšinek Skok D; Spasovska E; Boštjančič E; Glavač D BMC Med Genomics; 2019 Apr; 12(1):54. PubMed ID: 30987631 [TBL] [Abstract][Full Text] [Related]
32. A two-gene blood test for methylated DNA sensitive for colorectal cancer. Pedersen SK; Baker RT; McEvoy A; Murray DH; Thomas M; Molloy PL; Mitchell S; Lockett T; Young GP; LaPointe LC PLoS One; 2015; 10(4):e0125041. PubMed ID: 25928810 [TBL] [Abstract][Full Text] [Related]
33. Circulating tumor DNA methylation marker MYO1-G for diagnosis and monitoring of colorectal cancer. Lin WH; Xiao J; Ye ZY; Wei DL; Zhai XH; Xu RH; Zeng ZL; Luo HY Clin Epigenetics; 2021 Dec; 13(1):232. PubMed ID: 34961566 [TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of aberrant gene methylation in stool samples for colorectal cancer or adenomas: a meta-analysis. Yuan Y; Qu B; Yan J; Wang H; Yin L; Han Q Panminerva Med; 2015 Jun; 57(2):55-64. PubMed ID: 25256821 [TBL] [Abstract][Full Text] [Related]
35. The significance of DNA methylation profile in metastasis-related genes for the progression of colorectal cancer. Tokarz P; Pawlowska E; Bialkowska-Warzecha J; Blasiak J Cell Mol Biol (Noisy-le-grand); 2017 Feb; 63(2):79-87. PubMed ID: 28364795 [TBL] [Abstract][Full Text] [Related]
36. High potential of Moradi K; Babaei E; Rezvani N; Safaralizadeh R; Bashiri H; Feizi MAH Indian J Cancer; 2020; 57(2):166-171. PubMed ID: 32445320 [TBL] [Abstract][Full Text] [Related]
37. Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis. Yan H; He J; Guan Q; Cai H; Zhang L; Zheng W; Qi L; Zhang S; Liu H; Li H; Zhao W; Yang S; Guo Z Oncotarget; 2017 Jul; 8(29):47356-47364. PubMed ID: 28537885 [TBL] [Abstract][Full Text] [Related]
38. Highly sensitive fecal DNA testing of NDRG4 12b methylation is a promising marker for detection of colorectal precancerosis. Ji X; Sha J; Qian H; Zhang G; He T; Dang Y J BUON; 2021; 26(4):1239-1245. PubMed ID: 34564976 [TBL] [Abstract][Full Text] [Related]
39. Spectrin repeat containing nuclear envelope 1 and forkhead box protein E1 are promising markers for the detection of colorectal cancer in blood. Melotte V; Yi JM; Lentjes MH; Smits KM; Van Neste L; Niessen HE; Wouters KA; Louwagie J; Schuebel KE; Herman JG; Baylin SB; van Criekinge W; Meijer GA; Ahuja N; van Engeland M Cancer Prev Res (Phila); 2015 Feb; 8(2):157-64. PubMed ID: 25538088 [TBL] [Abstract][Full Text] [Related]
40. Stool methylated DNA markers decrease following colorectal cancer resection--implications for surveillance. Kisiel JB; Yab TC; Taylor WR; Mahoney DW; Ahlquist DA Dig Dis Sci; 2014 Aug; 59(8):1764-7. PubMed ID: 24993691 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]